Evidence map›Paper›PMID 42395457›Full record

ArticlebioRxiv : the preprint server for biology2026

Characterization of Electrophysiological and Transcriptomic Alterations in Patient-Derived Neurons from CHAMP1 Syndrome.

Dailey Nettles, Christina Stanton, Zach Hunter, Bryan Granger, Elizabeth Wallace, Andrew Lutsky, Suganya Subramanian, Meris Privette, Lori McMahon, Stefano Berto

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dailey NettlesDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Christina StantonDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Zach HunterDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Bryan GrangerDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Elizabeth WallaceDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Andrew LutskyDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Suganya SubramanianDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.
Meris PrivetteDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL.
Lori McMahonDepartment of Neuroscience, University of Virginia, Charlottesville, VA.
Stefano BertoDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC.ORCID 0000-0001-9028-9458

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
The Role of Early Life Stress in Feeding BehaviorsP20GM148302 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jose H Ledo · 2023 to 2026
$11.5M
Role of CHAMP1, a neurodevelopmental disorder high risk gene, in human brain development and functionR01HD113594 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Stefano Berto · 2024 to 2026
$1.5M
NCI NIH HHS P30 CA138313NICHD NIH HHS R01 HD113594NIGMS NIH HHS P20 GM148302
6 · The paper itself

Abstract

Mutations in chromosome alignment maintaining phosphoprotein 1 (CHAMP1) have been linked to neurodevelopmental disorders characterized by intellectual disability, developmental delay, and autism spectrum disorder. However, the cellular and electrophysiological mechanisms by which CHAMP1 mutations disrupt human neuronal development remain poorly understood. In the present study, we used patient-derived induced pluripotent stem cells (iPSCs) carrying two pathogenic CHAMP1 mutations and generated neural progenitor cells (NPCs) and excitatory neurons to investigate the effects of each mutation on neuronal maturation and function, DNA repair, and gene expression. Proliferative capacity declines with CHAMP1 dosage, while DNA repair dysfunction is allele-specific. Whole-cell patch-clamp electrophysiology revealed that CHAMP1 mutant neurons exhibit significant alterations in intrinsic membrane properties during early developmental stages, including depolarized resting membrane potential, reduced action potential firing, and impaired waveform kinetics. These functional deficits were accompanied by reduced sodium and potassium current densities, suggesting impaired ion channel accumulation during neuronal maturation. Furthermore, recordings of spontaneous excitatory postsynaptic currents indicated altered synaptic activity and reduced proportions of synaptically active neurons. Morphological analyses showed that CHAMP1-deficient neurons exhibit impaired neurite outgrowth and branching, supporting a defect in neuronal maturation. Single-nucleus transcriptomic profiling further revealed delayed developmental trajectories and mutation-specific dysregulation of synaptic gene programs enriched for autism, ADHD, and epilepsy risk genes. Together, these findings demonstrate that CHAMP1 mutations disrupt multiple aspects of neuronal development, including homologous recombination (HR) dysfunction in NPCs, membrane excitability, ion channel function, and synaptic connectivity. Our results provide insights into the neurobiological consequences of CHAMP1 mutations and establish patient-derived neurons as a platform to investigate cellular pathophysiology and potential therapeutic strategies for CHAMP1-associated neurodevelopmental disorders.

Identifiers

PMID42395457
PMCPMC13320776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.